Amdocs (NASDAQ:DOX) Issues FY 2025 Earnings Guidance

Key Points

• Amdocs (NASDAQ:DOX) updated its FY 2025 earnings guidance, projecting EPS of 6.960-7.020 and revenue of $4.5 billion-$4.6 billion, slightly aligning with consensus estimates.
• Recent analyst ratings show one downgrade from "buy" to "hold" and a consensus rating of "Moderate Buy" with an average target price of $105.33.
• Amdocs stock saw a 4.5% increase during trading, reaching $88.35, with a market cap of approximately $9.97 billion.

Amdocs (NASDAQ:DOX - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 6.960-7.020 for the period, compared to the consensus estimate of 6.973. The company issued revenue guidance of $4.5 billion-$4.6 billion, compared to the consensus revenue estimate of $4.5 billion. Amdocs also updated its Q4 2025 guidance to 1.790-1.850 EPS.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on DOX. Wall Street Zen cut Amdocs from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Wolfe Research began coverage on Amdocs in a research note on Tuesday, July 8th. They set an "outperform" rating for the company. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $105.33.

Amdocs Trading Up 4.5%

Amdocs stock traded up $3.78 during trading hours on Thursday, hitting $88.35. The stock had a trading volume of 989,780 shares, compared to its average volume of 704,349. The business's 50 day simple moving average is $90.27 and its 200-day simple moving average is $88.66. The stock has a market cap of $9.97 billion, a price-to-earnings ratio of 18.63, a P/E/G ratio of 1.40 and a beta of 0.51. Amdocs has a one year low of $78.61 and a one year high of $95.41. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.21.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.01. The firm had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.13 billion. Amdocs had a return on equity of 19.52% and a net margin of 11.39%. The company's revenue for the quarter was down 8.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.62 EPS. On average, equities analysts predict that Amdocs will post 6.21 EPS for the current fiscal year.

Institutional Trading of Amdocs

Several hedge funds and other institutional investors have recently bought and sold shares of DOX. Amundi raised its holdings in Amdocs by 73.0% in the 1st quarter. Amundi now owns 13,778 shares of the technology company's stock worth $1,217,000 after purchasing an additional 5,816 shares during the period. Millennium Management LLC raised its stake in shares of Amdocs by 458.3% in the first quarter. Millennium Management LLC now owns 67,047 shares of the technology company's stock valued at $6,135,000 after acquiring an additional 55,038 shares during the period. Goldman Sachs Group Inc. increased its holdings in Amdocs by 12.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company's stock worth $30,300,000 after purchasing an additional 37,087 shares during the period. Empowered Funds LLC boosted its position in Amdocs by 12.0% during the first quarter. Empowered Funds LLC now owns 15,979 shares of the technology company's stock valued at $1,462,000 after purchasing an additional 1,709 shares in the last quarter. Finally, Jane Street Group LLC boosted its stake in Amdocs by 195.4% in the first quarter. Jane Street Group LLC now owns 115,929 shares of the technology company's stock valued at $10,608,000 after acquiring an additional 76,683 shares in the last quarter. Institutional investors own 92.02% of the company's stock.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.